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Abstract
The development of genomic instability is an important
step in generating themultiple genetic changes required
for cancer. One consequence of genomic instability is
the overexpression of oncogenes due to gene amplifi-
cation. One mechanism for gene amplification is the
breakage/fusion/bridge (B/F/B) cycle that involves the
repeated fusion and breakage of chromosomes follow-
ing the loss of a telomere. B/F/B cycles have been
associated with low-copy gene amplification in human
cancer cells, and have been proposed to be an initiating
event in high-copy gene amplification. We have found
that spontaneous telomere loss on a marker chromo-
some 16 in a human tumor cell line results in sister
chromatid fusion and prolonged periods of chromo-
some instability. The high rate of anaphase bridges
involving chromosome 16 demonstrates that this insta-
bility results from B/F/B cycles. The amplification of
subtelomeric DNA on the marker chromosome provides
conclusive evidence that B/F/B cycles initiated by
spontaneous telomere loss are a mechanism for gene
amplification in human cancer cells.
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Introduction
Genomic instability is an important step in generating the
multiple genetic changes required for cancer [1–3].
Genomic instability can result in both the loss of tumor
suppressor genes through deletions or chromosome loss, or
the overexpression of oncogenes through gene amplification
[4,5 ]. Gene amplification can occur through a number of
different mechanisms. In human tumor cells, high-copy gene
amplification most often involves the formation of double-
minute (DM) chromosomes [6,7 ]. Gene amplification can
also result from the breakage/ fusion/bridge (B/F/B) cycles,
which were first described in maize [8]. B/F/B cycles are
initiated when broken chromosomes fuse and then break
during anaphase when the two centromeres are pulled in
opposite directions. The B/F/B cycle is then continued in the
next cell cycle when sister chromatids fuse following DNA
replication. B/F/B cycles have been found to be the primary
mechanism for gene amplification in hamster cells [9–12];
however, the importance of B/F/B cycles in genomic
instability in human cancer is unclear.
The ends of chromosomes, called telomeres, play an
important role in maintaining chromosome stability and
preventing chromosome fusion. Telomeres are composed
of a 6-bp repeat sequence and associated proteins that form
a cap that protects chromosome ends [13,14]. Telomeric
repeat sequences are added on by the enzyme telomerase,
which compensates for the loss of the ends of chromosomes
during cell division. In humans, telomerase activity is
expressed in germ line cells, but not in most somatic cells
[15]. As a result, in somatic cells, telomeres continue to
shorten with each cell division, which has been proposed to
be the mechanism for mediating cell senescence [16].
Consistent with this hypothesis, expression of the gene for
the catalytic subunit of telomerase is capable of extending the
lifespan of primary human fibroblasts [17]. Thus, to over-
come telomere shortening, immortalized cells invariably
regain the ability to maintain telomeres, either through the
activation of telomerase activity [16,18] or through the
activation of an alternative mechanism that appears to
involve recombination [19,20]. The importance of telomeres
in preventing chromosome fusion is illustrated by the mas-
sive increase in chromosome fusion observed in somatic
cells that fail to senesce and therefore continue to undergo
telomere shortening [18]. Increased chromosome fusion is
also seen in cells with mutations in genes that affect telomere
function [21–25]. The ability of cells to properly maintain
telomeres is therefore a critical factor in maintaining chro-
mosome stability.
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Although telomeres must be maintained for cells to
become immortal, cancer cells commonly have problems in
maintaining telomeres and preventing chromosome fusion.
Many cancer cells demonstrate a high frequency of telo-
mere associations involving chromosomes joined at or near
their telomeres, which has been proposed to result from a
failure to properly maintain telomere length [15]. Consistent
with this observation, many early passage tumor cells in
culture demonstrate telomere instability leading to chromo-
some fusion [26]. A variety of mechanisms may be involved
in spontaneous telomere loss. Fluctuations in telomerase
activity in some cancer cell lines have been demonstrated to
result in global changes in telomere length and increased
chromosome fusion [27,28]. However, other cancer cell
lines can demonstrate a high frequency of chromosomes
without detectable telomeres, which is independent of av-
erage telomere length [26,29], suggesting that stochastic
mechanisms can also result in telomere loss. Stochastic
mechanisms of spontaneous telomere loss could include
a failure to replicate telomeres during DNA synthesis or
double-strand breaks occurring within or near telomeric
repeat sequences, which has been shown to result in telo-
mere loss in mouse ES cells [30].
As first proposed by McClintock [8], the addition of
telomeres to the ends of broken chromosomes can promote
chromosome stability by preventing or terminating B/F/B
cycles. Broken chromosomes can acquire telomeres by a
variety of mechanisms. Telomeres can be added on directly
to the ends of broken chromosomes by telomerase, as
demonstrated in Tetrahymena [31] and yeast [32]. Direct
addition of telomeres to the ends of broken chromosomes
has been associated with human genetic disease [33–35],
and has been observed at the location of double-strand
breaks in mouse embryonic stem (ES) cells [36]. However,
it is unclear whether telomerase is involved in the direct
addition of telomeres in mammalian cells. Telomeres can
also be acquired through the translocation of the ends of
other chromosomes, as has been observed in human cancer
cells [37,38] and in mouse ES cells [30]. Finally, telomeres
can be acquired through break- induced replication, as has
been observed in yeast [39,40]. In break- induced replica-
tion, the broken end of the chromosome invades a region of
homology on another chromosome and replicates the end of
the chromosome. Whether break- induced replication occurs
in mammalian cells is not known.
Evidence that telomere loss and B/F/B cycles play an
important role in human cancer is provided by the presence
of a high frequency of anaphase bridges in many early
passage tumor cells [26] and tumors [41]. In addition,
structures consistent with B/F/B cycles have been observed
in low-copy gene amplification in some human tumor cells
lines [42,43]. B/F/B cycles could also be an early step in
high-copy gene amplification. Although human tumor cells in
culture selected for gene amplification usually contain DM
chromosomes, one clone with low-copy amplification
contained structures consistent with B/F/B cycles [44].
When placed under more stringent selection conditions, the
amplified genes in this clone converted to DM chromo-
somes, leading to the proposal that B/F/B cycles are an
early step in the formation of DM chromosomes. Consistent
with this hypothesis, regions amplified by B/F/B cycles
in hamster cells have also been shown to form DM
chromosomes [11].
We previously investigated the consequences of sponta-
neous telomere loss in a human tumor cell line that has a
herpes simplex virus thymidine kinase (HSV-tk ) selectable
marker gene integrated immediately adjacent to a telomere
[38]. Loss of the HSV-tk gene was found to be associated
with the formation of inverted repeats, large duplications, and
prolonged periods of instability in the ‘‘marker’’ chromosome
containing the telomeric plasmid sequences. These results
suggested that chromosome instability resulting from telo-
mere loss involved sister chromatid fusion and B/F/B
cycles. To confirm the presence of B/F/B cycles, we have
now analyzed the cells containing the unstable marker
chromosome for the presence of anaphase bridges. The
extent of amplification of subtelomeric DNA on the marker
chromosome was also investigated to determine whether
B/F/B cycles initiated by spontaneous telomere loss are a
mechanism for gene amplification in human cancer cells.
Materials and Methods
Cell Culture
The EJ-30 cell line (obtained from Dr. William Dewey,
University of California, San Francisco) was subcloned from
the EJ bladder cell carcinoma cell line, which is also named
MGH-U1 [45]. Clones A3 and B3 were isolated from EJ-30
following transfection with the pNCT- tel plasmid, and
contain a single copy of the plasmid integrated at the end
of a chromosome [38]. After isolation, the clones were
expanded to approximately 107 cells prior to Southern blot
analysis and isolation of subclones deficient in HSV-tk.
HSV-tk–deficient subclones were selected from multiple
experiments using medium containing both ganciclovir
(50 M) and G418 (400 g/ml) to ensure that some portion
of the plasmid was present to allow for analysis of the
recombination events involved.
Southern Blot Analysis
Genomic DNA purified as previously described [46] was
digested with restriction enzymes according to the manu-
facturer’s instructions. For analysis of terminal fragments,
the DNA was digested with BAL31 following the manu-
facturer’s recommendations (Promega, Madison, WI), ex-
tracted with phenol /chloroform, precipitated, resuspended,
and digested with BamHI. Genomic DNA was fractionated by
agarose gel electrophoresis using standard protocols,
depurinated by treatment with 0.25 M HCl for 30 minutes,
and transferred in 0.5 M NaOH onto a charged nylon
Hybond-N+ membrane (Amersham, Piscataway, NJ) using
a vacuum transfer apparatus (Amersham). Prehybridization
for 3 hours and hybridization overnight were performed at
658C in 5 SSPE, 5 Denhardt’s solution, 0.5% sodium
dodecyl sulfate (SDS), and 0.25 mg/ml salmon sperm DNA.
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Probes were labeled with [a32P]dCTP (New England
Nuclear, Chicago, IL) using a High Prime labeling kit
(Roche, Indianapolis, IN). Filters were washed three times
in 2 SSPE with 0.1% SDS at room temperature, twice in
1 SSPE with 0.1% SDS at 658C, and twice in 0.1 SSC
with 0.1% SDS at 658C.
Chromosome Analysis
For analysis of anaphase cells, cultures were grown as
monolayers in chamber slides and fixed with ice-cold
methanol for 15 minutes followed by ice-cold methanol:
acetone (1:1 vol /vol ) for 30 minutes. FISH analysis was
performed using Spectrum Green–labeled chromosome
16–specific painting probe (Vysis, Downers Grove, IL)
following the manufacturer’s protocol. DNA was counter-
stainedwith 4,6-diamino-2-phenylindole (DAPI). Anaphase
cells were identified by their characteristic chromosomal
configurations.
Preparation of metaphase chromosomes and hybrid-
izations were performed as previously described [47,48].
Cosmid clones RT99 (Genbank accession no. AC004653)
and 317H7 (Genbank accession no. AC005569) have been
mapped to the end of chromosome 16p [49]. These cosmids
were isolated from partially digested DNA libraries made
from flow-sorted human chromosome 16 [50]. To improve
separation of FISH signals, chromosomes were stretched.
Cells were treated with colcemid (0.4 g/ml, 30 minutes),
harvested by trypsinisation, swollen with a hypotonic solution
of 0.075 M KCl /serum (5:1 vol /vol ), and sedimented onto
glass slides for 5 minutes at 1000 rpm (Cytospin; Shandon,
Pittsburgh, PN). Chromosomes were fixed overnight in
methanol /acetic acid (3:1 vol /vol ). The BAC probes that
were used consisted of GS-121- I4, which is located a
maximum of 160 kb from the telomere on 16p, GS-240-G10
for the long arm of chromosome 16 (16q), and BAC GS-
121- I4, which is located a maximum of 200 kb from the
telomere on 16q [51].
Telomere analysis was performed as previously de-
scribed [52] using telomere-specific peptide nucleic acid
(PNA) probes labeled with Cy3 (Perseptive Biosystems,
Foster City, CA).
Results
Chromosome Instability Associated with Spontaneous
Telomere Loss in a Human Tumor Cell Line
The relationship between telomere loss and chromosome
instability in human cells was investigated using clone B3 of
the human EJ-30 bladder cell carcinoma cell line [38].
Clone B3 contains a selectable HSV-tk gene located
immediately adjacent to a telomere on chromosome 16
(Figure 1A ). Cell clones containing selectable marker genes
adjacent to a telomere are established by transfection with
linearized plasmids containing telomeric repeat sequences
on one end. The integration of the plasmid sequences on the
end of a broken chromosome results in a new telomere
‘‘seeded’’ from the telomeric repeat sequences within the
Figure 1. Structure of the integrated plasmid sequences and length of seeded
telomeres in EJ -30 clones A3 and B3. (A ) Clones A3 and B3 contain a single
copy of the pNCT- tel plasmid integrated on the end of a chromosome. The
locations of the cellular DNA, plasmid vector ( amp /ori ), neo gene, HSV - tk
gene, and telomeric repeat sequences are shown. The location of BamHI
restriction sites (Bm) used for Southern blot analysis and the size of the
BamHI restriction fragments are shown. (B ) Southern blot analysis of BamHI -
digested genomic DNA from clones A3 and B3, and subclones 1 through 5
selected at random from each clone. Hybridization was performed with the
pNCT - probe, which is identical to pNCT - tel except that it does not contain
telomeric repeat sequences. (C ) Southern blot analysis of BamHI -digested
genomic DNA from clone B3 and its subclones B3 -1 and B3 -2 after different
numbers of cell doublings using the pNCT- plasmid as a probe. The internal
BamHI fragments in clones A3 and B3 are both approximately 4.5 kb in length.
The terminal fragments containing 4.4 kb of plasmid sequences are
heterogeneous in length due to variability in the length of the telomeres in
different cells in the population. Molecular size markers consisting of Lambda
bacteriophage HindIII restriction fragments are shown.
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plasmid [53–55]. The seeded telomeres on these marker
chromosomes are elongated in culture, and their length and
dynamics become similar to the other telomeres in the cell
[29,56]. In the EJ-30 clones A3 and B3, the terminal BamHI
restriction fragments average approximately 7.5 and 9.5 kb,
respectively, indicating telomeres that average approxi-
mately 3 and 5 kb in length (Figure 1B ). Subclones of A3
and B3 selected at random demonstrated variability in the
length of the terminal restriction fragments, ranging from 7
to 10 kb in clone B3 and from 9 to 12 kb in clone A3
(Figure 1B ). With increasing time in culture, clone B3
showed no change in the length of the seeded telomere,
whereas subclones of B3 showed gradual changes in the
length of the seeded telomere (Figure 1C ). These results
are similar to those obtained with other tumor cell lines, in
which the length of the seeded telomeres is at equilibrium
in the original clones, whereas telomere length in sub-
clones is often not at equilibrium but returns to equilibrium
with time in culture [29,56]. Thus, the seeded telomeres in
clones of EJ-30 are relatively stable, although some va-
riation in telomere length is observed in different cells in the
population.
Selection with ganciclovir for cells that had lost the HSV-
tk gene provides a method for following the consequences of
spontaneous telomere loss on a specific chromosome
without selection for gene amplification. Clones of EJ-30
containing telomeric integration sites showed a high rate of
spontaneous loss of the HSV-tk gene (104 events/cell per
generation) as compared to clones with interstitial integra-
tion sites [38]. In contrast, the seeded telomeres in mouse
ES cells are relatively stable and spontaneous loss of the
HSV-tk gene is below the level of detection [30]. Thus, the
seeded telomeres in tumor cell lines are relatively unstable,
consistent with studies indicating telomere instability in tumor
cells and tumor cell lines [26,29]. The analysis of four HSV-
tk–deficient (HSV-tk  ) subclones of clone B3, G45, G55,
G60, and G71 demonstrated the presence of inverted
repeats within the plasmid sequences, whereas cytogenetic
analysis showed the presence of large duplications on the
end of the marker chromosome [30,38]. The heterogeneity
in the structure of the marker chromosome in different cells in
the population and the continued instability of the marker
chromosome in many second-generation subclones dem-
onstrated that this instability continues for many cell
generations. The combined results from these experiments
strongly indicated that sister chromatid fusion was the first
event leading to chromosome instability resulting from
spontaneous telomere loss.
Anaphase Bridges Associated with Chromosome Instability
Resulting from Spontaneous Telomere Loss
The presence of inverted repeats, large duplications, and
prolonged periods of chromosome instability following the
loss of a telomere are consistent with a mechanism involving
Figure 2. Themechanism of gene amplification involving B /F /B cycles. B /F /
B cycles are initiated when sister chromatids fuse following the loss of a
telomere. The resulting dicentric chromosome forms a bridge during
anaphase and breaks again, continuing the cycle until the chromosome
obtains a new telomere. Breakage at locations other than the site of fusion
results in amplification of sequences in one daughter cell and deletions in the
other daughter cell. The distance between the amplified arrays is dependent
upon the distance of the break from the site of fusion. The telomeres ( gray
squares ), centromeres ( circles ), and orientation of the subtelomeric se-
quences ( arrow ) are shown.
Figure 3. Anaphase bridges specific to chromosome 16 in subclone G71. The
staining of total chromatin with DAPI ( left panel, pseudo -colored orange ) is
used to identify anaphase cells without (A ) and with (B,C ) chromosome
bridges (arrows ). Hybridization with a chromosome 16–specific painting
probe ( center panel, green ) demonstrates that most anaphase bridges in
subclone G71 involve chromosome 16. The merged image showing both
DAPI staining and hybridization with the chromosome 16–specific probe is
also shown ( right panel ).
534 DNA Amplification by Breakage /Fusion /Bridge Cycles Lo et al.
Neoplasia . Vol. 4, No. 6, 2002
B/F/B cycles (Figure 2). To determine whether B/F/B
cycles are involved in the instability in the marker chromo-
some, we examined subclone G71 for the presence of
anaphase bridges, which are considered a hallmark of
chromosome fusion resulting from telomere loss [8,26,41].
Anaphase bridges were observed in 10% (21 of 200) of the
anaphase cells in subclone G71. In contrast, the parental B3
cell line had significantly fewer bridges in anaphase cells
(1 of 200). In addition, hybridization with a chromosome 16–
specific probe showed that the anaphase bridges in subclone
G71 consisted of chromosome 16 in 9 of 11 anaphase
bridges that were analyzed (Figure 3). The presence of a
high frequency of anaphase bridges involving chromosome
16 provides compelling evidence that the marker chromo-
some in subclone G71 is involved in B/F/B cycles.
DNA Amplification Resulting from B/F/B Cycles Initiated by
Spontaneous Telomere Loss
B/F/B cycles can result in amplification of DNA (Figure
2), and amplified regions consistent with B/F/B cycles have
been observed in a number of mammalian cells [9–12]. To
determine whether B/F/B cycles in clone B3 result in gene
amplification, metaphase chromosomes from subclone G71
were hybridized with cosmid RT99 that contains sequences
subtelomeric to the plasmid on the end of the marker
chromosome (Figure 4Ai ). The same metaphase chromo-
some preparations were also hybridized with a telomeric
probe to monitor the presence of a telomere (Figure 4Aii )
and chromosome 16–specific probes to identify the marker
chromosome (Figure 4, Aiii and iv ). A chromosome 16–
specific painting probe was used to identify both chromo-
some 16 homologs (Figure 4Aiii ), whereas hybridization with
two bacterial artificial chromosome (BAC) clones specific for
the p and q arms of chromosome 16 was used to distinguish
between the two homologs (Figure 4Aiv ). Due to the deletion
of approximately 4 Mb of DNA from the end of the p arm upon
integration of the telomeric plasmid in clone B3, the marker
chromosome does not hybridize with the p arm-specific BAC
clone GS-121- I4. In many metaphase spreads, the hybrid-
ization signal with the RT99 cosmid probe was located
internally within the marker chromosome (Figure 4Ai ),
consistent with previous results demonstrating duplications
on the end of chromosome 16 in subclones containing
inverted repeats [38]. The lack of a detectable telomere and
a rounded end on the p arm in approximately 20% of the cells
in subclone G71 were consistent with continued sister
chromatid fusion in many cells in the population (Figure
4Aii ). In addition, of 72 metaphase spreads analyzed, all but
one showed an increase in hybridization intensity of the
subtelomeric RT99 probe in the marker chromosome over
that observed in the other chromosome 16 homologue. In
approximately half of the metaphases examined (35 of 72),
the increase in hybridization intensity with RT99 was small
and localized in single spots (Figure 4Ai ). In most of the
other cells in the population (32 of 72), the increase in
hybridization was more pronounced and multiple spots were
observed (Figure 4B ). Only a small fraction of the cells
(4 of 72) contained multiple bands typical of the hybrid-
ization patterns previously reported for genes amplified by
B/F/B cycles in hamster [9–12] or human [42,43] cells.
Figure 4. Gene amplification resulting from the spontaneous telomere loss.
(A ) Metaphase chromosomes from subclone G71 hybridized with ( i ) a sub-
telomeric cosmid probe RT99 and counterstained with propidium iodide; ( ii ) a
telomere - specific PNA probe and counterstained with DAPI; ( iii ) a
chromosome 16–specific painting probe and counterstained with propidium
iodide; and ( iv ) both a chromosome 16q–specific BAC clone GS-240 -G10
( red ) and a chromosome 16p–specific BAC clone GS-121 - I4 ( green ). The
marker chromosome is identified by the absence of hybridization with the GS-
121 - I4 BAC clone due to the terminal deletion associated with integration of
the pNCT- tel plasmid. (B ) Two additional metaphase chromosomes of
subclone G71 demonstrating increased hybridization with the subtelomeric
cosmid probe RT99 and variability in the size of the fragment joined onto the
end of the marker chromosome. (C ) Three metaphase spreads containing
stretched chromosomes were hybridized with fluorescein - labeled cosmid
RT99 (green ) located immediately adjacent to the telomere and rhodamine -
labeled cosmid 317H7 ( red ) located 1 Mb from the telomere. Overlapping
RT99 and 317H7 hybridization signals appear yellow. Chromosomes were
counterstained with DAPI ( blue ). The inserts are magnified views of the
amplified regions.
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In contrast to the marker chromosome, the corresponding
region in the homologous chromosome in all of the meta-
phase spreads examined appeared normal with no indi-
cation of amplification.
To investigate the structure of the amplified region at
higher resolution, stretched metaphase chromosomes from
subclone G71 were hybridized simultaneously with a
fluorescein- labeled cosmid RT99 located adjacent to the
integration site, and a rhodamine- labeled cosmid 317H7
located 1 Mb from the integration site. Multiple hybridization
signals involving both cosmid probes were commonly
observed, demonstrating amplification of the subtelomeric
region (Figure 4C ). However, the amplified arrays did not
consist of alternating signals from the two cosmids, which
would result if the breaks occurred outside of the amplified
region (see Figure 2). Instead, most hybridization signals
involved cosmid RT99 adjacent to the site of fusion, with only
occasional signals involving the more distal cosmid 317H7.
This observation demonstrates that most breaks occurred
within 1 Mb of the site of fusion and, as a result, the se-
quences in clone 317H7 are often excluded from the am-
plified region. The presence of as many as six separate
hybridization signals with cosmid RT99 in some metaphase
spreads demonstrated that the marker chromosome had
been involved in at least three B/F/B cycles.
Discussion
The results presented with EJ-30 [38] and from other
studies involving human tumor cells in culture [26–29]
demonstrate that human tumor cells often have a high rate of
spontaneous telomere loss. A variety of factors could
contribute to this apparent inability to properly maintain
functional telomeres in the EJ-30 tumor cell line. One
possible mechanism is a periodic fluctuation in the level of
telomerase, which has been reported to result in a dramatic
shortening of telomeres in some cells in the population in
some tumor cell lines [27,28]. Some fluctuation in telomere
length is seen on the marker chromosome in clones of EJ-30
(Figure 1). However, analysis of telomeres in the HSV-tk–
deficient subclones using PNA probes showed that the
telomeres in these cells are not significantly shorter in length
than the parental cell lines (data not shown). Therefore, the
loss of the telomere on the marker chromosome in B3 results
from either a transient shortening of all telomeres, or
stochastic events occur that result in the complete loss of
individual telomeres. Regardless of the mechanism, it is
clear from our results that telomere loss can have a dramatic
influence on chromosome stability.
Previous studies on the mechanism of gene amplification
in mammalian cells have primarily focused on the analysis of
the structure of highly amplified regions. In the present study,
we have analyzed the mechanism of gene amplification by
following the fate of a single chromosome after the loss of a
telomere. As a result, we have been able to observe the early
steps involved in gene amplification, providing several
valuable insights into the role of B/F/B cycles in this
process. One important insight is that when a telomere is
not added to the end, the first event resulting from telomere
loss is often sister chromatid fusion. All four of the HSV-tk 
subclones of B3 that the telomere, had contained inverted
repeats involving the plasmid sequences [30,38]. Similar
inverted repeats were also seen in four HSV-tk  mouse ES
cell subclones in which telomere loss was induced with the
I–SceI endonuclease, although in the ES cells the addition of
a telomere at the site of the break was the most common
event observed [30]. The instability in the marker chromo-
some in all of the mouse and human subclones containing
inverted repeats [30,38] also demonstrates that sister
chromatid fusion is often followed by B/F/B cycles. Sister
chromatid fusion is also an important mechanism in
perpetuating B/F/B cycles, as demonstrated by the cytoge-
netic analysis showing the apparent fusion of the ends of
sister chromatids lacking a telomere in subsequent cell
cycles (Figure 4A).
The demonstration in our study of gene amplification and
anaphase bridges in the same chromosome proves con-
clusively that B/F/B cycles can lead to gene amplification in
human cancer cells. Previous studies have shown an
increased rate of anaphase bridges in human cancer cells
[26,57] and the presence of amplified regions consistent
with B/F/B cycles [42–44]. However, the experimental
systems used in these studies do not allow for the analysis of
both anaphase bridges and gene amplification in the same
cell line. The presence of bridges involving chromosome
16 in 10% of the anaphase cells in subclone G71 also
demonstrates that B/F/B cycles can last for many gen-
erations after the initial sister chromatid fusion. This
observation is consistent with the lack of detectable
telomeres on the end of the marker chromosome in
approximately 20% of the cells in subclone G71 [38]. In
contrast, a similar study in mouse ES cells found that B/F/B
cycles were generally much shorter in duration, with the
marker chromosome acquiring a telomere through the
translocation of fragments from other chromosomes [30].
In some instances, telomere acquisition in subclone G71
was also accompanied by translocation of fragments from
other chromosomes [38]. However, in some cells, new telo-
meres were observed on the marker chromosome without
detectable translocations, indicating that either microtrans-
locations or direct addition of telomeric repeats was involved.
Both microtranslocations [37] and direct addition of telo-
meres [33–36] have been observed in human cells.
A third important observation in the present study is the
small size of the amplified regions in subclone G71. Previous
studies have observed that anaphase bridges usually break
within preexisting fragile sites [12,43]. However, the results
presented here demonstrate a tendency to break within 1 Mb
of the original site of fusion. This breakage near the site of
fusion could be due to the creation of a new fragile site
caused by the presence of the large inverted repeats, which
have been shown to be highly unstable [58–60]. A tendency
to break near the site of fusion would also explain why the
marker chromosome appears relatively ‘‘normal’’ in many
cells in the population in subclone G71 despite having
undergone one or more sister chromatid fusions [38]. As a
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result, the typical ladders seen in genes amplified by B/F/B
cycles in hamster cells are uncommon in subclone G71.
However, this could also be due to the lack of selection for
gene amplification in our system, because the genes that are
amplified are often far from the initial site of sister chromatid
fusion. Regardless, it is clear from our studies that B/F/B
cycles can result in the amplification of relatively small
regions that are similar in size to the amplified regions
commonly seen in human cancer cells [4 ].
Another interesting observation made in our study is the
relatively modest amount of amplification that was observed
despite the prolonged B/F/B cycles involving the marker
chromosome. Despite the fact that there was no selection for
gene amplification, the continuation of B/F/B cycles for
more than 20 generations in many cells in the population
would provide ample opportunity for extensive gene ampli-
fication. These results suggest that B/F/B cycles are not an
efficient mechanism for generating high-copy gene amplifi-
cation in human cells, which could explain why highly
amplified genes in human cells are not found in structures
typically associated with B/F/B cycles [6,7]. Despite this
apparent inefficiency in generating high-copy DNA amplifi-
cation, B/F/B cycles may be important in gene amplification
in human cancer. Many cancer cell lines and early passage
cancer cells in culture have high rates of telomere
associations [15] and anaphase bridges associated with
telomere instability [26,57], suggesting a high rate of
chromosome fusion. In fact, low-copy amplified arrays
typical of B/F/B cycles have been observed in some human
cancer cell lines [42,43]. The presence of inverted repeats in
amplified regions in human cancer cells [61] would also
suggest that B/F/B cycles can play a role as an early event
in the generation of highly amplified genes. Although most
highly amplified genes in human cancer cells are located on
DM chromosomes, this amplification may have been initiated
by B/F/B cycles in some instances. Genes amplified initially
through B/F/B cycles have been demonstrated to convert to
DM chromosomes [11,44], which would be consistent with
our observation that the region containing the inverted
repeats appears to form a new fragile site. Cells that convert
to DM chromosomes appear to have a selective advantage
under more stringent selection conditions [44], possibly
because DM chromosomes are a more efficient mechanism
for generating high-copy gene amplification than B/F/B
cycles.
B/F/B cycles can also lead to chromosome instability by
promoting recombination with other chromosomes, which
can promote nonreciprocal translocations, transfer of the
amplified genes to other chromosomes, and complex
chromosome rearrangements [11,38]. The types of trans-
locations and chromosome rearrangements seen in the
human tumor cells [38] and mouse ES cells [30] in our
studies are typical of the rearrangements seen in tumors in
telomerase-deficient mice [62] and human tumors [63].
B/F/B cycles resulting from spontaneous telomere loss are
therefore likely be an important mechanism for generating
both gene amplification and the chromosome rearrange-
ments commonly found in human cancer.
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